Halozyme Therapeutics, Inc. Second Quarter 2024 Financial & Operating Results NASDAQ: HALO August 6, 2024 1 Forward Looking Statements In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future growth, financial performance (including the Company's 2024 guidance and longer term financial outlook through 2028) and expectations for profitability, revenue (including ex ...